Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of ...

FDA Recall #D-0210-2025 — Class I — December 23, 2024

Recall #D-0210-2025 Date: December 23, 2024 Classification: Class I Status: Ongoing

Product Description

Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.

Reason for Recall

Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Recalling Firm

Astellas Pharma US Inc. — Northbrook, IL

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

3,500 30-count bottles

Distribution

Nationwide in the USA

Code Information

Lot# 0R3092A, EXP 03/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated